Staphylococcus Aureus Bacteremia: Impact of an Intervention Program in Improving the Clinical Management and Review of the Clinical and Molecular Epidemiology
NCT01971762 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2014-12-05
Summary
Staphylococcus aureus bacteremia: impact of an intervention program in improving the clinical management and review of the clinical and molecular epidemiology.
Conditions
- Staphylococcus Aureus Bacteremia
Interventions
- BEHAVIORAL
-
Follow recommendations based on scientific evidence to S. aureus bacteremia management
- BEHAVIORAL
-
Not to follow recommendations based on scientific evidence to S. aureus bacteremia management
Sponsors & Collaborators
-
Fundación Pública Andaluza Progreso y Salud
lead OTHER
Principal Investigators
-
Jesús Rodríguez-Baño · Hospital Universitario Virgen Macarena
Eligibility
- Min Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-04-30
- Primary Completion
- 2011-10-31
- Completion
- 2012-01-31
Countries
- Spain
Study Locations
More Related Trials
-
Evaluation of an Algorithm for Identifying Persistent Nasal Staphylococcus Aureus Carriage in a Cohort of Healthy Volunteers and Patients Regularly Monitored at the CHU of Saint-Etienne
NCT02557568 ·Status: COMPLETED ·Phase: NA
-
Staphylococcus Aureus Caught in Action at the Site of Infection
NCT04781569 ·Status: COMPLETED
-
Staphylococcus Aureus Bacteraemia (SAB)-Support-Study
NCT06249451 ·Status: COMPLETED ·Phase: NA
-
Adjunctive Fosfomycin for Treatment of Staphylococcus Aureus Bacteraemia
NCT06695832 ·Status: ACTIVE_NOT_RECRUITING
-
Chart Review of Outcome of Treatment for S. Aureus Bacteremia
NCT00304902 ·Status: COMPLETED
-
Immune Resolution After Staphylococcus Aureus Bacteremia
NCT01879761 ·Status: ACTIVE_NOT_RECRUITING
-
Efficacy of Cloxacillin and Fosfomycin Combination Versus Cloxacillin Monotherapy in Patients With MSSA Bacteremia
NCT03959345 ·Status: TERMINATED ·Phase: PHASE4
-
The Natural History of Community-Associated MRSA Infections and Decolonization Strategies
NCT00513799 ·Status: COMPLETED ·Phase: NA
-
Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia
NCT00548002 ·Status: COMPLETED
-
Staphylococcus Aureus Nasal Carriage
NCT02796690 ·Status: COMPLETED
-
Impact MRSA -PCR on Patient Management
NCT03096405 ·Status: COMPLETED
-
Antimicrobial Drug Use and Resistant Staphylococcus Aureus
NCT01075451 ·Status: COMPLETED
-
A First in Human Trial to Assess the Safety and Immunogenicity of LTB-SA7 Vaccine Against Staphylococcus Aureus.
NCT06719219 ·Status: COMPLETED ·Phase: PHASE1
-
Early Infectious Disease Consultations in Staphylococcus Aureus Bacteremia
NCT00622882 ·Status: UNKNOWN ·Phase: NA
-
Safety, Pharmacokinetics and Efficacy of KBSA301 in Severe Pneumonia (S. Aureus)
NCT01589185 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Virulence Determinants in S Aureus Bacteremia
NCT00319826 ·Status: COMPLETED
-
Collect Clinical Data in Chinese Patients Received CUBICIN Treatment for Actual Usage in Clinical Practice
NCT01212601 ·Status: COMPLETED
-
Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA Bacteremia
NCT01898338 ·Status: COMPLETED ·Phase: PHASE3
-
Probability of Target Attainment With Standard Intermittent Bolus Administration of Cefazolin in Patients With Complicated Infections Caused by Staphylococcus Aureus
NCT04503252 ·Status: COMPLETED
-
Study of the Nasal Intracellular Reservoir of Staphylococcus Aureus in Patients With S. Aureus Bacteremia
NCT06594250 ·Status: RECRUITING
-
Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylococcus Aureus Bacteremia Receiving Standard-of-Care (SOC) Antibiotics
NCT03162250 ·Status: COMPLETED ·Phase: PHASE1
-
Nasal Carrying by Staphylococcus Aureus ST398 Strains in Community and Hospital Settings
NCT03869255 ·Status: UNKNOWN
-
Recurrent S. Aureus Infections in Osteoarticular Infections
NCT04712123 ·Status: UNKNOWN
-
Staphylococcus Aureus Carriers Students Nursing Oxacillin Resistant
NCT00518076 ·Status: UNKNOWN
-
Study to Evaluate the Efficacy, Safety and Tolerability of 3% LTX-109 for Nasal Decolonisation of Staphylococcus Aureus
NCT05889351 ·Status: COMPLETED ·Phase: PHASE2